FotonMedix
Il dolore articolare profondo richiede una potenza laser controllata
Multi-wavelength penetration, thermal control, tissue-specific dosing
A 9-year-old Labrador can finish a short walk and still struggle to stand when it reaches the clinic door. A sport horse can look sound at a walk yet show a clear shortened stride after flexion testing. These are the cases where the practical problem is not whether light can reach tissue. The problem is whether enough useful energy reaches the painful structure without turning the superficial tissue into the treatment bottleneck.
That is the real challenge behind La laserterapia nei cani e laserterapia equina.
A thick canine coat, subcutaneous fat, fascia and muscle can absorb and scatter part of the optical energy before it reaches a hip, stifle, tendon or ligament. A horse creates an even larger version of the same problem because the target may sit beneath dense muscle or a thick fascial layer.
High-intensity Class IV laser treatment gives the clinician more energy to work with, but more energy does not automatically mean a better treatment.
The useful question is more precise:
How can the clinician deliver a clinically meaningful dose at depth while controlling superficial heating and maintaining patient tolerance?
That question determines whether cani da terapia laser receive becomes a repeatable rehabilitation procedure or simply another machine-based treatment added to the schedule.
The Treatment Room Problem Is Usually Deeper Than the Skin
Veterinary rehabilitation teams rarely struggle because the skin cannot absorb light.
They struggle because the target is underneath it.
A canine hip joint may sit several centimeters below the surface. A stifle is surrounded by muscle, fascia, capsule and connective tissue. An equine suspensory ligament can be covered by substantial soft tissue and has a relatively poor vascular environment compared with muscle.
The photons entering the skin therefore encounter several optical environments before reaching the intended target.
Some energy is absorbed.
Some is scattered.
Some continues toward deeper tissue.
The remaining fluence decreases with depth, and the rate of decrease is influenced by wavelength, absorption coefficient, scattering coefficient, tissue composition and geometry.
This is why simply reporting a treatment as “30 W for ten minutes” tells another clinician surprisingly little.
The treatment could produce a very different tissue response depending on whether the operator used continuous emission, pulsed emission, a narrow contact area, a broad scanning field, one wavelength or multiple wavelengths.
A systematic veterinary review published in Animals evaluated 45 relevant studies involving dogs, cats and horses and specifically identified wavelength, laser class, dose, frequency and treatment duration as major sources of variation. The authors concluded that there was no universally accepted optimal protocol and that incomplete reporting of treatment parameters made clinical interpretation difficult.
That finding is extremely important for B2B veterinary laser equipment.
The value of a high-power system is not simply its maximum output.
The value is the ability to control the variables that determine where the energy goes.
Why Tissue Creates an Energy Attenuation Problem
In simplified terms, optical energy decreases as it travels through biological tissue.
The decrease is not linear.
A useful conceptual model is exponential attenuation, where increasing depth progressively reduces the remaining photon fluence. The exact curve changes with tissue type and wavelength.
Muscle is different from fat.
Fat is different from tendon.
Tendon is different from blood-rich muscle.
Inflamed tissue can also behave differently from normal tissue because blood volume, water content and cellular structure change.
This is why a canine arthritis protocol should not be copied directly to a horse tendon.
The anatomical target changes.
The optical path changes.
The required energy distribution changes.
The thermal tolerance changes.
The rehabilitation objective changes.
The 2023 review by Jessica Bunch in Veterinary Clinics of North America: Small Animal Practice describes photobiomodulation as a growing veterinary modality used in rehabilitation, sports medicine and general practice while also noting that evidence varies considerably between indications.
That distinction is useful in clinical marketing because it keeps the discussion grounded.
Laser treatment is not one standardized therapy.
It is a family of wavelength- and dose-dependent interventions.
Why 810 nm Remains Important for Deep-Tissue Treatment
The near-infrared region around 800 nm is frequently considered useful for deeper photobiomodulation because tissue scattering is lower than at shorter wavelengths and absorption by major chromophores is relatively favorable.
The 810 nm wavelength is therefore a logical component in a multi-wavelength high-intensity system.
The clinical reasoning is not that 810 nm magically travels straight through the body.
Non è così.
Scattering still occurs.
Absorption still occurs.
Energy still declines with depth.
The advantage is that the optical balance can be favorable enough to deliver meaningful photon fluence deeper into musculoskeletal tissue than many shorter wavelengths.
FotonMedix’s VetMedix-Max platform combines 650, 810, 915, 940 and 980 nm channels with a stated peak power of 38 W, super-pulse operation and thermal sensation control. The veterinary system is positioned for pain relief, inflammation management, swelling reduction, wound care and selected veterinary procedures.
Its HorseVet-Max and HorseVet 3000U5 platforms similarly combine five wavelengths for equine rehabilitation, with the HorseVet 3000U5 specified at 30 W and applications including muscle, bone, fascia, joint and pain-related rehabilitation.
The technical advantage of having multiple wavelengths is not that every wavelength must be used during every session.
It is the ability to change the optical strategy when the target changes.
The 980 nm Question Is Really a Water and Thermal Question
980 nm becomes particularly interesting when high-intensity treatment is used.
At this wavelength, water absorption is stronger than in parts of the lower near-infrared range. The result is a greater tendency toward photothermal interaction.
This can be useful.
It also means the clinician must manage it.
The biological tissue is not just a passive optical filter. It is a dynamic thermal environment.
Energy absorbed by water-containing tissue raises local temperature. Blood perfusion can carry heat away. Tissue conduction spreads heat laterally and longitudinally. If energy deposition is faster than heat removal, local temperature can rise.
This is where treatment technique becomes more important than the number printed on the front panel.
A clinician treating a deep canine hip may want meaningful peak output but does not necessarily want continuous maximum thermal loading at the skin.
A pulsed strategy can change that balance.
A high peak can occur during the active portion of the pulse while the average thermal burden remains lower than an equivalent continuous exposure.
FotonMedix’s VetMedix-Max provides continuous, pulse and super-pulse modes. The manufacturer’s stated super-pulse configuration reaches up to 38 W peak power and is designed to provide deeper penetration with adjustable thermal sensation.
For a clinical team, that means peak power becomes one tool rather than the entire treatment protocol.
980 nm and Hemoglobin Need a More Careful Explanation
It is common in commercial laser discussions to describe 980 nm as a “hemoglobin wavelength.”
That wording is too simplistic.
Hemoglobin absorption is highly wavelength-dependent and differs between oxygenated and deoxygenated states. Biological tissue contains multiple chromophores, so the final absorption behavior is the combined result of blood, water, melanin and other tissue components.
Near 980 nm, water absorption becomes an increasingly important contributor to tissue interaction.
That does not mean hemoglobin is irrelevant.
It means that a clinician should avoid presenting one chromophore as the entire mechanism.
Blood also matters because perfusion changes the thermal environment.
A well-perfused muscle can remove heat more effectively than poorly perfused tissue.
At the same time, increased blood volume can alter local optical absorption.
This creates a dynamic relationship between optical energy and tissue temperature.
Per La laserterapia nei cani, that relationship matters when treating large muscle groups, arthritic joints or regions with variable circulation.
Per laserterapia equina, it becomes even more relevant when the target is surrounded by dense muscle and fascia.
1470 nm Shows Why Wavelength Selection Cannot Be Generic
1470 nm provides a useful contrast.
Water absorption is substantially stronger around 1470 nm than at 980 nm. This means that the effective optical penetration is much more localized, and energy can produce a stronger photothermal interaction over a shorter distance.
This property is particularly useful in laser surgery.
FotonMedix’s SurgMedix platform is designed around 1470 nm and 980 nm configurations for high-energy surgical applications, where tissue cutting, coagulation and controlled tissue ablation require a different optical strategy from non-invasive rehabilitation.
Questa distinzione è importante.
A wavelength that is highly effective at producing localized surgical tissue effects should not automatically be treated as the ideal wavelength for deep non-invasive canine arthritis treatment.
The underlying physics is the same.
The clinical objective is different.
In a surgical environment, strong local water absorption can be desirable.
In rehabilitation, the clinician often wants controlled energy deposition through a larger volume without producing excessive superficial thermal accumulation.
This is one reason a multi-wavelength system is more clinically flexible than a machine that forces every patient into the same spectral window.
Duty Cycle Controls the Conflict Between Power and Heat
This is perhaps the most useful concept when explaining high-intensity laser treatment to a veterinary rehabilitation team.
Peak power tells you how intense the active pulse can be.
Average power tells you more about the energy delivered over time.
Duty cycle determines how much of the treatment cycle the laser is actually emitting.
If a system operates at a high peak level but only emits during part of each cycle, the average energy delivery can be substantially lower than continuous operation at the same peak level.
That creates a thermal management opportunity.
During the active period, the tissue receives a strong optical stimulus.
During the inactive period, heat begins to diffuse and blood perfusion can contribute to thermal removal.
This does not make any high-power setting automatically safe.
A low duty cycle cannot compensate for inappropriate positioning, excessive exposure, poor temperature monitoring or unsuitable patient selection.
It simply gives the clinician another control variable.
FotonMedix describes pulse and super-pulse modes specifically in terms of intermittent energy delivery and thermal management, with its veterinary platform designed to provide adjustable thermal sensation.
That is clinically more meaningful than simply advertising “38 W.”
The Canine Case Where Continuous Power Was the Wrong Choice
Quello che segue è un simulated clinical training case, not a published patient record. The parameters are designed to demonstrate how a veterinary team could structure a high-intensity Class IV treatment protocol and record treatment progression.
Simulated Case Identification
A 9-year-old male neutered Golden Retriever presents with chronic bilateral hip osteoarthritis.
The dog weighs 34 kg.
Radiographs show severe bilateral degenerative changes, with the right hip producing the greater functional limitation.
The dog has difficulty rising, avoids stairs and develops a shortened hind-limb stride after several minutes of walking.
The owner reports that medication improves comfort but does not fully restore normal activity.
The rehabilitation team decides to incorporate high-intensity laser treatment into a multimodal program rather than use it as a replacement for veterinary pain management.
Simulated Clinical Treatment Table
| Variabile clinica | Case Record |
|---|---|
| Dipartimento | Veterinary Rehabilitation and Physical Medicine |
| Numero del caso simulato | VR-LASER-2026-041 |
| Paziente | Golden Retriever |
| Età | 9 anni |
| Il sesso | Maschio, castrato |
| Peso corporeo | 34 kg |
| Primary Condition | Artrosi bilaterale dell’anca nei cani |
| Radiographic Grade | Severe, Grade III training classification |
| Dominant Side | Right hip |
| Functional Problem | Difficulty rising, stair avoidance, shortened hind-limb stride |
| Piattaforma terapeutica | High-intensity veterinary Class IV laser |
| Strategia della lunghezza d'onda | 650 nm + 810 nm + 915 nm + 940 nm + 980 nm |
| Potenza di picco iniziale | 24 W |
| Maximum Simulated Peak Power | 30 W |
| Frequenza | 20 Hz |
| Ciclo di funzionamento iniziale | 40% |
| Initial Session Energy | 1,200 J |
| Sessione 3: Energia | 1,500 J |
| Sessione 6: Energia | 1,800 J |
| Frequenza di trattamento | 2 sessioni a settimana |
| Initial Course | 3 settimane |
| Reassessment | Weeks 1, 3 and 6 |
| Treatment Objective | Pain modulation and improved rehabilitation tolerance |
| Additional Therapy | Controlled walking, hip mobility work and progressive strengthening |
These parameters are an example of clinical documentation rather than a universal prescription.
The clinician would adjust energy, duty cycle, scanning speed and treatment area according to the patient’s size, coat, tissue depth, response and the specific indication.
Sessione 1
The first session is deliberately conservative.
The operator uses a 24 W peak setting with a 40% duty cycle and 20 Hz pulsing.
The handpiece is continuously moved across the hip region rather than held stationary over a single small point.
The initial total energy is 1,200 J.
The dog tolerates the procedure without withdrawal, agitation or excessive thermal discomfort.
The immediate functional change is modest.
The dog rises more readily after treatment but still demonstrates a shortened hind-limb stride.
This is a realistic outcome.
A single treatment should not be presented as if it can reverse chronic structural osteoarthritis.
The first session establishes tolerance and gives the clinician information about the patient’s thermal response.
Sessione 2
The dog remains comfortable overnight.
The owner reports that the dog is more willing to walk to the garden.
The clinician maintains the same frequency and duty cycle.
The treatment field is expanded to include the periarticular musculature rather than focusing only on the hip joint projection.
This is important because chronic osteoarthritis changes movement patterns.
The dog may overload the gluteal muscles, lumbar region and contralateral limb.
The rehabilitation target is therefore functional rather than purely anatomical.
Sessione 3
The treatment energy is increased to approximately 1,500 J.
The peak setting remains below the system’s maximum capability.
The duty cycle remains at 40%.
The owner reports that the dog is standing more quickly and voluntarily walks for longer.
A functional pain-interference score decreases from a simulated 7/10 at baseline to 5/10.
The clinician does not interpret this as evidence of structural cartilage regeneration.
It is recorded as an early functional response.
End of Week 3
After six sessions, the simulated case record shows:
| Outcome Measure | Linea di base | Settimana 1 | Settimana 3 |
|---|---|---|---|
| Pain interference score | 7/10 | 6/10 | 4/10 |
| Rising from rest | Markedly difficult | Moderato | Mite |
| Stair tolerance | Avoids stairs | 3 steps | 8 steps |
| Hind-limb stride | Clearly shortened | Moderately shortened | Mildly shortened |
| Daily walking tolerance | 8 minutes | 12 minuti | 20 minutes |
| Owner activity score | 4/10 | 5/10 | 7/10 |
| Energia della sessione | 1,200 J | 1,500 J | 1,800 J |
| Potenza massima | 24 W | 26 W | 30 W |
| Ciclo di lavoro | 40% | 40% | 45% |
| Frequenza | 20 Hz | 20 Hz | 20 Hz |
The progression is intentionally gradual.
The operator does not begin at maximum output simply because the equipment can produce it.
That is the practical difference between equipment capability and treatment protocol.
What the Canine Evidence Supports
There is actual clinical evidence supporting Class IV photobiomodulation as a potential adjunct for canine osteoarthritis.
A randomized double-blinded controlled trial published in 2022 evaluated 20 dogs and 40 osteoarthritic joints. The dogs received either a 21-day meloxicam protocol or Class IV photobiomodulation over three weeks. The study measured pain, function, gait, stiffness and quality of life at multiple follow-up points. The photobiomodulation group showed statistically better results for several pain and functional measures at days 8, 15 and 30.
The study is valuable because it did not rely solely on an owner’s impression.
It included multiple clinical metrology instruments and repeated follow-up.
Another clinical study involving 23 dogs with naturally occurring osteoarthritis used objective activity monitoring and weekly laser treatments. Activity and step counts increased during the treatment period, supporting the idea that functional activity can be a useful endpoint when evaluating veterinary rehabilitation.
At the same time, the systematic review literature remains cautious.
The 2023 systematic review of veterinary laser therapy identified inconsistent protocols, variable study quality and insufficient standardization across dogs and horses.
That means a serious veterinary laser supplier should not promise that every arthritic dog will produce the same response.
The stronger commercial argument is controllability.
Why Large Dogs Need a Different Treatment Mindset
A 7 kg dog and a 40 kg dog do not present the same optical problem.
The larger dog can have:
- More subcutaneous tissue
- Greater muscle thickness
- A deeper hip joint
- Aree di trattamento più ampie
- Greater total energy requirements
- More challenging thermal management
This is where a high-power platform becomes clinically useful.
The system needs enough peak output to compensate for attenuation, but the operator must retain control over thermal exposure.
VetMedix-Max combines five wavelengths with a stated 38 W peak output, super-pulse capability, depth-maintaining technology and temperature indication.
That configuration is more relevant to deep canine treatment than simply increasing continuous output without thermal feedback.
The treatment head also matters.
A small spot can concentrate energy quickly.
A broader treatment field can distribute energy across a larger anatomical region.
For a large dog with hip arthritis, the second strategy may be preferable when the objective includes the surrounding musculature rather than only the joint projection.
Equine Laser Therapy Creates an Even Larger Optical Challenge
Now move from a 34 kg dog to a 550 kg Warmblood.
The same basic question becomes much harder.
A horse’s major muscle groups are substantial.
The target may be the proximal suspensory region, hamstring group, gluteal muscle, back, stifle or other deep musculoskeletal structure.
The horse also needs to return to movement.
For an athletic horse, “pain relief” is only one part of the rehabilitation objective.
The clinician wants improved movement quality, controlled tissue loading and a gradual return to work.
Qui è dove laserterapia equina becomes closely connected to sports medicine.
A 2025 chapter on Laser Therapy in Equine Rehabilitation by Steve Adair of the University of Tennessee describes laser use across equine rehabilitation and discusses applications related to tissue repair, swelling, pain and wound healing.
A scoping review of equine rehabilitation literature found that exercise, electrotherapy and hydrotherapy were among the most frequently reported rehabilitation techniques, while also noting a relatively small number of high-quality clinical trials and a need for better parameterization.
The lesson is similar to canine rehabilitation.
The laser should be integrated into the rehabilitation plan.
It should not become the entire rehabilitation plan.
Simulated Equine Suspensory Rehabilitation Case
The following case is also a simulated clinical training case, designed to demonstrate how a high-intensity equine protocol might be structured.
Identificazione del caso
A 7-year-old Warmblood gelding weighing approximately 560 kg presents with left forelimb lameness.
Ultrasonography identifies a moderate core lesion in the proximal suspensory ligament.
The rehabilitation team classifies the lesion as Grade II for this simulated protocol.
The horse shows a shortened stride and discomfort during palpation.
The goal is to support the rehabilitation process while controlled exercise is progressively reintroduced.
Simulated Equine Treatment Table
| Variabile clinica | Case Record |
|---|---|
| Dipartimento | Equine Sports Medicine and Rehabilitation |
| Numero del caso simulato | EQ-LASER-2026-018 |
| Paziente | Warmblood gelding |
| Età | 7 anni |
| Il sesso | Uomo |
| Peso corporeo | 560 kg |
| Diagnosi | Proximal suspensory ligament injury |
| Simulated Lesion Grade | Grade II |
| Dominant Limb | Left forelimb |
| Piattaforma terapeutica | HorseVet 3000U5 |
| Strategia della lunghezza d'onda | 810 nm + 915 nm + 980 nm |
| Potenza di picco | 30 W |
| Frequenza | 50 Hz |
| Ciclo di lavoro | 50% |
| Energy Density Target | 12–15 J/cm² |
| Energia totale della sessione | Approximately 2,400 J |
| Durata della sessione | 15–20 minutes |
| Frequenza | 3 sessioni a settimana |
| Initial Course | 4 weeks |
| Riabilitazione | Controlled walking and progressive loading |
| Imaging Follow-Up | Week 4 and Week 8 |
HorseVet 3000U5 is specified by FotonMedix with 650, 810, 915, 940 and 980 nm wavelengths and 30 W output, with applications covering muscle, bone, fascia, joint injuries and pain. The platform also provides super-pulse, pulse and continuous modes.
The 50% duty cycle in this simulated protocol is not intended as a universal equine prescription.
It demonstrates the reasoning process.
The horse needs a large treatment area.
The tissue is dense.
The operator needs meaningful peak energy.
At the same time, the clinician does not want uncontrolled thermal accumulation over a relatively small treatment region.
Settimana 1
The horse receives three sessions.
The handpiece is moved along the suspensory region rather than parked directly over the lesion.
The first objective is tolerance and controlled energy delivery.
Palpation sensitivity decreases modestly.
The horse remains lame but demonstrates less resistance during the initial portion of controlled walking.
Settimana 2
The treatment energy remains around 2,400 J per session.
The clinician maintains the same duty cycle rather than increasing power simply because the horse tolerates the treatment.
This is important.
Tissue remodeling is not accelerated indefinitely by increasing energy.
Biological systems have response windows.
The veterinary team therefore uses clinical findings and rehabilitation progression to determine whether the treatment needs to change.
Settimana 4
The simulated horse shows improved stride length at walk and reduced sensitivity during palpation.
Ultrasonography demonstrates improved organization within the lesion, but the horse is not immediately returned to full athletic work.
Controlled exercise remains part of the plan.
This is where equine rehabilitation differs from a simple pain-treatment model.
A horse can feel better before the tissue has regained sufficient mechanical strength.
The laser may support the rehabilitation environment, but the return-to-work decision must still be based on veterinary assessment, imaging and tissue capacity.
Why Laser Therapy Dogs Should Not Be Treated Like a Small Horse
The keywords may sit next to each other in a search engine, but the clinical problems are different.
Cani da terapia laser often involves:
- Osteoartrite
- Displasia dell'anca
- Stifle disease
- Riabilitazione postoperatoria
- Muscle pain
- Wound management
- Neurological rehabilitation
Equine cases more often involve:
- Tendon injury
- Ligament injury
- Stiramento muscolare
- Performance fatigue
- Infiammazione articolare
- Mal di schiena
- Sports rehabilitation
- Recovery from repetitive microtrauma
The same high-intensity Class IV platform can be adapted to both fields, but the treatment protocol must follow the anatomy.
That is why FotonMedix has separate veterinary and equine product configurations.
VetMedix-Max emphasizes veterinary treatment and surgical versatility.
HorseVet 3000U5 is designed around the practical demands of large-animal rehabilitation, including a built-in battery configuration and a 30 W balance between output and field usability.
LaserMedix-MAX provides the broader physiotherapy platform with the same five-wavelength 30 W configuration, while the surgical platform uses a different wavelength strategy for more localized tissue interaction.
The equipment architecture therefore follows the clinical environment.
What a Good Laser Protocol Should Record
A treatment record should contain more than total joules.
At minimum, a professional veterinary department should record:
Informazioni per il paziente
Species, breed, age, sex, weight and diagnosis.
Obiettivo anatomico
Exact joint, muscle, tendon, ligament or wound region.
Lunghezza d'onda
The wavelengths actually used during the session.
Peak and Average Output
Peak output is not interchangeable with average output.
Frequenza d'impulso
The frequency used during pulsed treatment.
Ciclo di lavoro
The percentage of time the laser is actively emitting.
Tempo di trattamento
Total treatment duration.
Energia
Total delivered joules and, when appropriate, energy density.
Area di trattamento
The approximate area over which the energy was distributed.
Risposta termica
Patient tolerance, surface temperature observations and any signs of excessive heat.
Functional Outcome
Pain score, gait, range of motion, activity level or another clinically meaningful measurement.
This level of documentation helps a clinic identify which protocols are actually useful.
It also makes the system easier to standardize when several veterinarians or rehabilitation therapists work with the same patients.
The Most Important Difference Between More Power and Better Treatment
A machine with more power gives the clinician more available energy.
It does not automatically produce better clinical outcomes.
The treatment becomes better when the available energy can be controlled.
For deep canine tissue, the operator needs to compensate for optical attenuation without overheating the surface.
For equine muscle and tendon, the operator needs to distribute sufficient energy over a much larger treatment field.
For acute inflammation, a pulsed protocol may provide a more comfortable thermal profile.
For chronic stiffness, the clinician may tolerate a different energy distribution.
For surgical applications, 1470 nm may be useful because of its strong water absorption.
For non-invasive rehabilitation, a broader near-infrared strategy may be more appropriate.
The wavelength is therefore part of the clinical decision.
Power is part of the clinical decision.
Duty cycle is part of the clinical decision.
Treatment geometry is part of the clinical decision.
None of them should be considered independently.
Where High-Intensity Laser Fits Beside Conventional Veterinary Care
The strongest case for veterinary laser therapy is not that it replaces everything else.
It is that it can add another controllable modality to an existing rehabilitation program.
A dog with osteoarthritis may still need weight control, exercise modification, medication, joint support, strength training or orthopedic intervention.
A horse with a ligament injury still needs controlled loading, imaging and a carefully staged return to exercise.
Laser therapy can be positioned between these approaches as a non-invasive treatment modality intended to support pain management, tissue response and rehabilitation tolerance.
The evidence supports cautious optimism rather than exaggerated promises.
The randomized canine osteoarthritis trial found meaningful improvements in several clinical measures following Class IV photobiomodulation.
The veterinary systematic review also makes clear that the field still needs better studies, better dose reporting and more consistent protocols.
That is not a weakness in the concept.
It is a reason for clinicians to document treatment carefully.
A clinic that records wavelength, peak output, duty cycle, frequency, treatment area, energy and functional outcome can build a much more useful internal evidence base than a clinic that simply writes “laser performed.”
The Practical Advantage for a Veterinary B2B Buyer
For a veterinary hospital, rehabilitation center or equine sports medicine practice, the purchase decision should be based on workflow.
A high-intensity system needs to handle repeated treatments.
It needs enough output for large anatomical targets.
It needs multiple wavelength options when tissue depth varies.
It needs pulse control when thermal accumulation becomes the limiting factor.
It should give the operator meaningful feedback about treatment temperature and patient response.
FotonMedix’s veterinary platform provides five wavelengths, super-pulse, pulse and continuous modes, and a stated depth-maintaining system. The company specifies 38 W peak power for VetMedix-Max and 30 W for HorseVet 3000U5.
Those specifications become meaningful only when connected to the clinical problem.
A 38 W peak output is useful because it provides headroom for deeper treatment.
A 30 W equine platform is useful because large-animal treatment requires practical energy delivery across large tissue regions.
Multiple wavelengths are useful because not every target has the same optical characteristics.
Thermal control is useful because energy that creates patient discomfort cannot be delivered repeatedly at clinically useful levels.
That is the real B2B value.
Final Clinical Perspective
The most convincing La laserterapia nei cani cases are not the ones with the biggest energy number.
They are the cases where the dog starts moving more comfortably and the rehabilitation team can explain why the protocol was selected.
The same principle applies to laserterapia equina.
A sport horse does not need a machine because “more watts” sounds impressive.
It needs a treatment system that can deliver meaningful energy to a deep musculoskeletal target while allowing the veterinarian to control thermal load and treatment progression.
And for cani da terapia laser, the real-world benefit is usually found in the functional details.
The dog gets up faster.
The dog walks farther.
The dog tolerates rehabilitation exercises better.
The owner sees fewer difficult moments during normal daily activity.
Those changes matter more than the number on a treatment screen.
High-intensity Class IV laser therapy should therefore be viewed as a controlled energy-delivery platform rather than a simple heating device or a generic pain machine.
The physics starts with photon attenuation.
The clinical decision continues with wavelength selection.
980 nm introduces a stronger interaction with tissue water than many lower near-infrared wavelengths and therefore requires careful thermal management.
1470 nm demonstrates an even stronger water-absorption profile and is particularly relevant to localized surgical tissue effects rather than being automatically transferred into non-invasive rehabilitation.
Pulse frequency and duty cycle then provide another level of control, allowing high peak output to be separated from continuous thermal loading.
That combination is what makes modern multi-wavelength Class IV systems useful for both canine and equine rehabilitation.
Traditional veterinary care remains indispensable.
Medication can control pain.
Exercise can restore function.
Weight management can reduce mechanical stress.
L'intervento chirurgico può correggere i problemi strutturali, quando indicato.
Diagnostic imaging can identify the pathology and monitor tissue recovery.
Laser therapy does not need to replace those approaches to be valuable.
Its strongest role is as a controllable, non-invasive treatment modality that can be fitted into the broader clinical plan.
For B2B veterinary buyers, that is the more defensible way to evaluate a system.
Do not ask only how powerful the laser is.
Ask how precisely that power can be delivered.
Do not ask only how many wavelengths are available.
Ask whether the wavelength selection matches the tissue and clinical objective.
Do not ask only how many joules can be delivered.
Ask how those joules are distributed through tissue and over time.
And do not judge the treatment only by immediate warmth.
Judge it by patient tolerance, functional recovery, repeatability and the quality of the rehabilitation process that follows.
That is the difference between owning a high-power laser and actually building a useful veterinary laser therapy program.